SANDOZ INC. et al v. UNITED THERAPEUTICS CORPORATION et al
| SANDOZ INC. and RAREGEN, LLC |
| UNITED THERAPEUTICS CORPORATION and SMITHS MEDICAL ASD, INC. |
| 3:2019cv10170 |
| April 16, 2019 |
| US District Court for the District of New Jersey |
| Anti-Trust |
| 15 U.S.C. ยง 1 |
| Plaintiff |
Docket Report
RSS Track this Docket
This docket was last retrieved on June 16, 2021. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 4 NOTICE of Appearance by THOMAS D. PEASE on behalf of RAREGEN, LLC (PEASE, THOMAS) |
| Filing 3 Corporate Disclosure Statement by RAREGEN, LLC identifying PBM Capital Finance, LLC as Corporate Parent.. (PEASE, THOMAS) |
| Filing 2 Corporate Disclosure Statement by SANDOZ INC. identifying NOVARTIS AG as Corporate Parent.. (KRAMER, JENNY) |
| Filing 1 COMPLAINT against SMITHS MEDICAL ASD, INC., UNITED THERAPEUTICS CORPORATION (Filing and Admin fee $ 400) with JURY DEMAND, filed by SANDOZ INC., RAREGEN, LLC. (Attachments: #1 Civil Cover Sheet)(KRAMER, JENNY) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
